Related Experiment Video

Updated: Jul 19, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors

A Beltran1, S Parikh, Y Liu

  • 1Department of Pharmacology and the Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365, USA.

Oncogene
|October 24, 2006
PubMed

Insights

Researchers developed artificial transcription factors (ATFs) to reactivate the silenced maspin tumor suppressor gene in aggressive cancer cells, offering a new therapeutic strategy to inhibit tumor growth and invasion.

Area of Science:

  • Molecular Biology
  • Cancer Therapeutics
  • Epigenetics

Background:

  • Reactivating endogenous tumor suppressors is a key cancer therapy strategy.
  • Tumor suppressor genes like maspin are often silenced in aggressive cancers.
  • Current tools for reactivation are limited, especially for epigenetically silenced genes.

Purpose of the Study:

  • To develop a novel approach for specifically re-activating silenced tumor suppressors in cancer cells.
  • To target the Mammary Serine Protease Inhibitor (maspin) tumor suppressor, which is silenced by promoter methylation in aggressive epithelial tumors.
  • To investigate the therapeutic potential of artificial transcription factors (ATFs) for cancer treatment.

Main Methods:

  • Designed artificial transcription factors (ATFs) composed of zinc-finger (ZF) domains targeting the maspin promoter.
  • Linked ZF domains to the VP64 activator domain for enhanced transcription.
  • Delivered ATFs to breast tumor cells and evaluated maspin re-activation, apoptosis induction, invasion inhibition, and tumor growth suppression in vivo.

Main Results:

  • Designed ATFs demonstrated high-affinity and selective binding to target sequences in vitro.
  • One ATF successfully re-activated maspin in cell lines with epigenetically silenced promoters.
  • The ATF induced apoptosis, reduced tumor cell invasion in vitro, and suppressed tumor growth in a xenograft mouse model.

Conclusions:

  • Artificial transcription factors (ATFs) can specifically re-activate epigenetically silenced tumor suppressors like maspin.
  • ATFs represent a promising novel therapeutic strategy for cancer by acting as molecular switches.
  • This approach holds potential for blocking tumor growth and progression in aggressive cancers.

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...